Allianz Asset Management GmbH - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 231 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.72 and the average weighting 0.1%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$33,576,000
+378.1%
361,267
+206.3%
0.02%
+360.0%
Q3 2021$7,023,000
+56.4%
117,932
+79.1%
0.01%
+25.0%
Q2 2021$4,490,000
+6.7%
65,841
+8.5%
0.00%0.0%
Q1 2021$4,210,000
-20.4%
60,671
-11.8%
0.00%
-20.0%
Q4 2020$5,287,000
-43.9%
68,809
-45.4%
0.01%
-54.5%
Q3 2020$9,431,000
+23.9%
126,097
+4.3%
0.01%
+22.2%
Q2 2020$7,613,000
+97.3%
120,939
+31.6%
0.01%
+80.0%
Q1 2020$3,859,000
-14.3%
91,873
-7.3%
0.01%
+25.0%
Q4 2019$4,501,000
+10.0%
99,086
+10.8%
0.00%0.0%
Q3 2019$4,092,000
-32.9%
89,443
-14.0%
0.00%
-33.3%
Q2 2019$6,101,000
+34.5%
104,063
+2.8%
0.01%
+50.0%
Q1 2019$4,536,000
+78.0%
101,187
+54.6%
0.00%
+33.3%
Q4 2018$2,549,000
+237.6%
65,456
+298.9%
0.00%
+200.0%
Q3 2018$755,000
+19.7%
16,409
+13.4%
0.00%0.0%
Q2 2018$631,000
-84.7%
14,475
-86.2%
0.00%
-75.0%
Q1 2018$4,129,000104,5380.00%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Prosight Management, LP 164,300$9,633,0004.86%
Atika Capital Management LLC 230,000$13,485,0002.65%
DAFNA Capital Management LLC 93,942$5,508,0002.07%
PFM Health Sciences, LP 1,828,378$107,198,0002.04%
Perceptive Advisors 1,380,171$80,919,0001.86%
Eversept Partners, LP 73,501$4,309,3641.21%
Partner Investment Management, L.P. 18,159$1,065,0001.13%
Rhenman & Partners Asset Management AB 170,000$9,967,0001.10%
EMERALD ADVISERS, LLC 425,510$24,948,0001.00%
EMERALD MUTUAL FUND ADVISERS TRUST 388,418$22,773,0000.90%
View complete list of ARENA PHARMACEUTICALS INC shareholders